• A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing
• A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an EGFR tyrosine kinase inhibitor-treated non-small-cell lung cancer patient
• A syngeneic spontaneous zebrafish model of <em>tp53</em>-deficient, EGFR^vIII, and PI3KCA^H1047R-driven glioblastoma reveals inhibitory roles for inflammation during tumor initiation and relapse in v
• Aberrant HIF1- α and SIX-1 Expression is Associated with Poor Prognosis in Acute Myeloid Leukemia Patients with Isocitrate Dehydrogenase 1 Mutations
• Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1
• Advances in Anti-Cancer Drug Development: Metformin as Anti-Angiogenic Supplemental Treatment for Glioblastoma
• Aggressive pituitary tumors and carcinomas: modern classification, advances and prospects in treatment
• Auto-loaded TRAIL-exosomes derived from induced neural stem cells for brain cancer therapy
• Autologous stem cell transplantation in adults with atypical teratoid rhabdoid tumor: a case report and review
• Bibliometric and visualized analysis of the applications of exosomes based drug delivery
• CD57 defines a novel cancer stem cell that drive invasion of diffuse pediatric-type high grade gliomas
• Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone
• CENPA facilitates glioma stem cell stemness and suppress ferroptosis to accelerate glioblastoma multiforme progression by promoting GBP2 transcription
• Clinical Characteristics and Delayed Diagnosis of Pediatric Patients Presenting to the Emergency Department With a Newly Diagnosed Central Nervous System Tumor: A Single Institutional Experience
• Clinical outcome, radiological findings, and genetic features of IDH-mutant brainstem glioma in adults
• Clinical practice in European centres treating paediatric posterior fossa tumours with pencil beam scanning proton therapy
• Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid
• Diagnostic performance of 3.0 Tesla diffusion tensor imaging in the assessment of brain stem glioma grading
• Discovery and Optimization of N-Arylated Tetracyclic Dicarboximides That Target Primary Glioma Stem-like Cells
• Dual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers
• Early rhombic lip Protogenin(+ve) stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma
• Editorial Expression of Concern: Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization
• Effect of luteolin on glioblastoma's immune microenvironment and tumor growth suppression
• Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells
• Embryonal tumor with multilayered rosettes: a clinicopathological analysis of three cases
• EphA3 CAR T cells are effective against glioblastoma in preclinical models
• Evaluation of secretome biomarkers in glioblastoma cancer stem cells: A bioinformatics analysis
• Exosomes as drug delivery systems in glioma immunotherapy
• Fatigue following head and neck cancer radiotherapy: a systematic review of dose correlates
• FERMT1 suppression induces anti-tumor effects and reduces stemness in glioma cancer cells
• Gene regulatory network topology governs resistance and treatment escape in glioma stem-like cells
• Glial and glioneuronal tumors: Navigating the complexity of evolving concepts and new classification
• Glioblastoma microenvironment-from biology to therapy
• Glioma Stem Cells as Promoter of Glioma Progression: A Systematic Review of Molecular Pathways and Targeted Therapies
• Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma
• H3K27-Altered Diffuse Midline Glioma of the Brainstem: From Molecular Mechanisms to Targeted Interventions
• High Level Immunoglobulin Gene Expression and Reduced Intra-tumoral Bacteria Associated With the Transition from Initial to Progressive Diffuse Intrinsic Pontine Glioma
• Host-defence caerin 1.1 and 1.9 peptides suppress glioblastoma U87 and U118 cell proliferation through the modulation of mitochondrial respiration and induce the downregulation of CHI3L1
• Human glioblastoma-derived cell membrane nanovesicles: a novel, cell-specific strategy for boron neutron capture therapy of brain tumors
• Hyperthermia for Targeting Cancer and Cancer Stem Cells: Insights from Novel Cellular and Clinical Approaches
• Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments
• Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in Glioblastoma Multiforme: a systematic review going beyond pathologic implications
• Impact of brain organoid-derived sEVs on metastatic adaptation and invasion of breast carcinoma cells through a microphysiological system
• Interaction of NF-κB and FOSL1 drives glioma stemness
• Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD
• Intratumoral Cell Heterogeneity in Patient-Derived Glioblastoma Cell Lines Revealed by Single-Cell RNA-Sequencing
• Kinetic Trajectories of Glucose Uptake in Single Cancer Cells Reveal a Drug-Induced Cell-State Change Within Hours of Drug Treatment
• KR158 Spheres Harboring Slow-Cycling Cells Recapitulate High-Grade Glioma Features in an Immunocompetent System
• Lactoferrin/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood-brain-barrier and glioblastoma stem cells
• Leading medulloblastoma to a differentiation end
• Letter to the Editor: "The relationship between imaging features, therapeutic response, and overall survival in pediatric diffuse intrinsic pontine glioma"
• Lineage specification in glioblastoma is regulated by METTL7B
• M6A-methylated circPOLR2B forms an R-loop and regulates the biological behavior of glioma stem cells through positive feedback loops
• Mechanistic insights into medulloblastoma relapse
• MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma
• Moving towards a connectomic view of neuro-oncology
• Multi-modal fusion and feature enhancement U-Net coupling with stem cell niches proximity estimation for voxel-wise GBM recurrence prediction()
• Multifraction stereotactic radiotherapy utilizing inhomogeneous dose distribution for brainstem metastases: a single-center retrospective analysis
• Navigating glioblastoma complexity: the interplay of neurotransmitters and chromatin
• Neural Progenitor Cell-Mediated Magnetic Nanoparticles for Magnetic Resonance Imaging and Photothermal Therapy of Glioma
• Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort
• Non-Tumor Cells within the Tumor Microenvironment-The "Eminence Grise" of the Glioblastoma Pathogenesis and Potential Targets for Therapy
• NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors
• Olanzapine suppresses mPFC activity-norepinephrine releasing to alleviate CLOCK-enhanced cancer stemness under chronic stress
• Oncolytic virotherapy improves immunotherapies targeting cancer stemness in glioblastoma
• Ophiobolin A derivatives with enhanced activities under tumor-relevant acidic conditions
• P2X7 receptor antagonism by AZ10606120 significantly depletes glioblastoma cancer stem cells in vitro
• PBI-05204, a supercritical CO(2) extract of Nerium oleander, suppresses glioblastoma stem cells by inhibiting GRP78 and inducing programmed necroptotic cell death
• Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma
• PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression
• Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme
• Prediction of auditory brain stem responses damage in patients with head-and-neck cancers receiving radiotherapy using the functional assays of normal tissue complication probability models
• Protocol for qualitative analysis of lysosome immunoprecipitation from patient-derived glioblastoma stem-like cells
• PTBP1-mediated repression of neuron-specific CDC42 splicing constitutes a genomic alteration-independent, developmentally conserved vulnerability in IDH-wildtype glioblastoma
• Racial and social-economic inequalities in systemic chemotherapy use among adult glioblastoma patients following surgery and radiotherapy
• Related mechanisms, current treatments, and new perspectives in meningioma
• Reprogramming Glioblastoma Cells into Non-Cancerous Neuronal Cells as a Novel Anti-Cancer Strategy
• Research progress on function and mechanism of long non-coding RNA in glioma
• Role of renin angiotensin system inhibitors and metformin in Glioblastoma Therapy: a review
• SENP1-Mediated deSUMOylation Regulates the Tumor Remodeling of Glioma Stem Cells Under Hypoxic Stress
• SMARCC2 silencing suppresses oncogenic activation through modulation of chromatin accessibility in breast cancer
• Stemness subtypes in lower-grade glioma with prognostic biomarkers, tumor microenvironment, and treatment response
• Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy
• Targeted Alpha Therapy for Glioblastoma: Review on In Vitro, In Vivo and Clinical Trials
• Targeting ARNT attenuates chemoresistance through destabilizing p38α-MAPK signaling in glioblastoma
• Targeting drug resistance in glioblastoma (Review)
• Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)
• The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells
• The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma
• The unfolded protein response machinery in glioblastoma genesis, chemoresistance and as a druggable target
• The USP10/13 inhibitor, spautin-1, attenuates the progression of glioblastoma by independently regulating RAF-ERK mediated glycolysis and SKP2
• TRIM24 Cooperates with Ras Mutation to Drive Glioma Progression through snoRNA Recruitment of PHAX and DNA-PKcs
• TRIM37 interacts with EZH2 to epigenetically suppress PTCH1 and regulate stemness in glioma stem cells through sonic hedgehog pathway
• Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma
• UCHL3 induces radiation resistance and acquisition of mesenchymal phenotypes by deubiquitinating POLD4 in glioma stem cells
• Unveiling the Complex Ecosystem of Breast Cancer: Crucial Insights for Patients and Doctors
• Ursolic acid inhibits the proliferation of triple-negative breast cancer stem-like cells through NRF2-mediated ferroptosis
• USP25 Elevates SHLD2-Mediated DNA Double-Strand Break Repair and Regulates Chemoresponse in Cancer
• Utilizing human cerebral organoids to model breast cancer brain metastasis in culture
• Vasorin promotes endothelial differentiation of glioma stem cells via stimulating the transcription of VEGFR2